| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |